CML-IN-1, also known as compound 7 and compound 4, is a potent anticancer agent that demonstrates a strong induced-apoptosis effect in the human chronic myeloid leukemia (CML) cell line K562. It diminishes protein phosphorylation within the PI3K/Akt signaling pathway to exert its effects and suppresses cell proliferation through the inhibition of the MEK/ERK signaling pathway in colorectal cancer [1] [2].
Molecular Weight:
540.58
CAS Number:
[2235393-30-1]
Formula:
C21H23F3N8O2S2
Target:
Apoptosis|||MEK|||PI3K
T78608
* VAT and and shipping costs not included. Errors and price changes excepted
